INVO Fertility to Participate in Lytham Partners Investor Conference

SARASOTA, Fla., Sept. 25, 2026 /CourierPR/ -- INVO Fertility, a healthcare fertility company, will participate in the Lytham Partners Fall 2026 Investor Conference, taking place virtually from September 29 to 30, 2026. The company will present a webcast at 11:30 a.m. ET on Tuesday, September 29.

The webcast will be accessible through the conference website at https://lythampartners.com/fall2026/ or directly at https://app.webinar.net/Yy1V3pgKbZQ. Participants will also have the opportunity to schedule one-on-one meetings with management.

INVO Fertility, headquartered in the United States, focuses on expanding access to assisted reproductive technology (ART) care. The company's principal commercial strategy involves building, acquiring, and operating fertility clinics and related businesses and technologies. INVO Fertility currently operates four clinics in the U.S. and continues to engage in the sale and distribution of INVOcell, a proprietary medical device that enables fertilization and early embryo development to occur within the woman's body.

INVO Fertility’s mission is to provide innovative solutions in the field of fertility. The company’s INVOcell technology stands out as a revolutionary advancement, offering a unique approach to in vitro fertilization (IVF) and intravaginal culture (IVC) procedures. By allowing fertilization and early embryo development to take place within the woman's body, INVOcell aims to enhance the patient experience and improve outcomes.

The company’s participation in the Lytham Partners Fall 2026 Investor Conference is a significant step in its ongoing efforts to engage with investors and stakeholders. This event provides a platform for INVO Fertility to share its vision, progress, and future plans with a broader audience, fostering dialogue and collaboration in the healthcare and fertility sectors.